Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Katsumata, H. Tomioka, T. Sumi, S. Yamashita, M. Takagi, F. Kato, R. Nakamura, Y. Koyanagi, T. Aoki, K. Kato (2003)
Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimensCancer Chemotherapy and Pharmacology, 51
B. F. Pavlyuk (2007)
Candidates’s Dissertation in Chemistry
W. Humphrey, A. Dalke, K. Schulten (1996)
VMD: visual molecular dynamics.Journal of molecular graphics, 14 1
J. Denton, M. Lui, T. Aoki, J. Sebolt, E. Takeda, J. Eble, J. Glover, G. Weber (1982)
Enzymology of pyrimidine and carbohydrate metabolism in human colon carcinomas.Cancer research, 42 3
A. Wagstaff, T. Ibbotson, K. Goa (2003)
Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer.Drugs, 63 2
L. Beigelman M. P. Liu (1018)
M. P. Liu, L. Beigelman, E. Levy, et al., Am. J. Physiol. 274(6), Part 1, G1018 (1998).
T. Ishikawa, M. Utoh, N. Sawada, Miwa Nishida, Y. Fukase, F. Sekiguchi, H. Ishitsuka (1998)
Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts.Biochemical pharmacology, 55 7
B. Jimenez, P. Kranz, C. Lee, A. Gero, W. O'Sullivan (1989)
Inhibition of uridine phosphorylase from Giardia lamblia by pyrimidine analogs.Biochemical pharmacology, 38 21
T. Halgren, R. Murphy, R. Friesner, Hege Beard, L. Frye, W. Pollard, J. Banks (2004)
Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.Journal of medicinal chemistry, 47 7
C. Lee, B. Jimenez, W. O'Sullivan (1988)
Purification and characterization of uridine (thymidine) phosphorylase from Giardia lamblia.Molecular and biochemical parasitology, 30 3
Leslie Walton, Cindy Richards, Lynn Elwell (1989)
Nucleotide sequence of the Escherichia coli uridine phosphorylase (udp) gene.Nucleic acids research, 17 16
J. Moyer, J. Oliver, R. Handschumacher (1981)
Salvage of circulating pyrimidine nucleosides in the rat.Cancer research, 41 8
Mengping Liu, Deliang Cao, R. Russell, R. Handschumacher, G. Pizzorno (1998)
Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors.Cancer research, 58 23
(2009)
Implications of the structure of human uridine phosphorylase 1 on the development of novel inhibitors for improving the therapeutic window of fluoropyrimidine chemotherapy.
G. Pizzorno, L. Yee, Barbara Burtness, J. Marsh, J. Darnowski, M. Chu, Shih Chu, Edward Chu, J. Leffert, R. Handschumacher, P. Calabresi (1998)
Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor.Clinical cancer research : an official journal of the American Association for Cancer Research, 4 5
K. Park, M. Kouni, T. Krenitsky, S. Chu, S. Cha (1986)
Inhibition of uridine phosphorylase from Escherichia coli by benzylacyclouridines.Biochemical pharmacology, 35 21
J. Karle, L. Anderson, R. Cysyk (1984)
Effect of plasma concentrations of uridine on pyrimidine biosynthesis in cultured L1210 cells.The Journal of biological chemistry, 259 1
Z. Lucas (1967)
Pyrimidine Nucleotide Synthesis: Regulatory Control during Transformation of Lymphocytes in vitroScience, 156
E. Declercq (1980)
Antiviral and antitumor activities of 5-substituted 2'-deoxyuridines.Methods and Findings in Experimental and Clinical Pharmacology, 2
E. Clercq, J. Descamps, P. Somer, P. Barr, A. Jones, R. Walker (1979)
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.Proceedings of the National Academy of Sciences of the United States of America, 76 6
A. Lashkov, N. Zhukhlistova, A. Gabdoulkhakov, A. Shtil, R. Efremov, C. Betzel, A. Mikhailov (2010)
The X-ray structure of Salmonella typhimurium uridine nucleoside phosphorylase complexed with 2,2'-anhydrouridine, phosphate and potassium ions at 1.86 A resolution.Acta crystallographica. Section D, Biological crystallography, 66 Pt 1
E. Sivridis (2000)
Thymidine phosphorylase activity in normal, hyperplastic and neoplastic endometrium--correlation with intratumoral angiogenesis.Advances in experimental medicine and biology, 476
M. Venturini (2002)
Rational development of capecitabine.European journal of cancer, 38 Suppl 2
Schrödinger Maestro (2009)
Maestro, Schrödinger, LLC, New York (New York, 2009).
J. Schüller, J. Cassidy, E. Dumont, B. Roos, S. Durston, L. Banken, M. Utoh, K. Mori, E. Weidekamm, B. Reigner (2000)
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patientsCancer Chemotherapy and Pharmacology, 45
J. Niedzwicki, Shih Chu, M. Kouni, Elizabeth Rowe, Cha Sungman (1982)
5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase.Biochemical pharmacology, 31 10
L. Paege, F. Schlenk (1952)
Bacterial uracil riboside phosphorylase.Archives of biochemistry and biophysics, 40 1
D. Spoel, E. Lindahl, B. Hess, G. Groenhof, A. Mark, H. Berendsen (2005)
GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 26
A. Vita, A. Amici, T. Cacciamani, M. Lanciotti, G. Magni (1986)
Uridine phosphorylase from Escherichia coli B. Enzymatic and molecular properties.The International journal of biochemistry, 18 5
F. Naguib, M. Kouni, S. Chu, S. Cha (1987)
New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers.Biochemical pharmacology, 36 13
P. Finan, P. Koklitis, E. Chisholm, G. Giles (1984)
Comparative levels of tissue enzymes concerned in the early metabolism of 5-fluorouracil in normal and malignant human colorectal tissue.British Journal of Cancer, 50
L. Griffiths, I. Stratford (1997)
Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.British Journal of Cancer, 76
S. Cha (1989)
Development of inhibitors of pyrimidine metabolism.Yonsei medical journal, 30 4
M. Kouni, M. Kouni, F. Naguib (1993)
Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.Cancer research, 53 16
J. Moyer, J. Henderson (1985)
Salvage of uridine in the mouse. Effect of uridine phosphorylase pretreatment.Biochemical pharmacology, 34 1
T. Caradoc-Davies, S. Cutfield, I. Lamont, J. Cutfield (2004)
Crystal structures of Escherichia coli uridine phosphorylase in two native and three complexed forms reveal basis of substrate specificity, induced conformational changes and influence of potassium.Journal of molecular biology, 337 2
D. Cao, R. Russell, Dekai Zhang, J. Leffert, G. Pizzorno (2002)
Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.Cancer research, 62 8
J. Choi, C. Shin, M. Choi, S. Yoon, J. Ryu, Jae‐Chul Lee, Won‐Ki Kim, M. Kouni, K. Ko (2008)
Uridine protects cortical neurons from glucose deprivation-induced death: possible role of uridine phosphorylase.Journal of neurotrauma, 25 6
P. Schwartz, R. Moir, C. Hyde, P. Turek, R. Handschumacher (1985)
Role of uridine phosphorylase in the anabolism of 5-fluorouracil.Biochemical pharmacology, 34 19
Mengping Liu, L. Beigelman, E. Lévy, R. Handschumacher, Giuseppe Pizzorno (1998)
Discrete roles of hepatocytes and nonparenchymal cells in uridine catabolism as a component of its homeostasis.The American journal of physiology, 274 6
A. Leyva, I. Kraal, J. Lankelma, J. Delemarre, H. Pinedo (1983)
High uridine phosphorylase activity in human melanoma tumor.Anticancer research, 3 4
E. Morgunova, Al'bert Mikhailov, Alexander Popov, Elena Blagova, E. Smirnova, B. Vainshtein, C. Mao, S. Armstrong, S. Ealick, Andrey Komissarov, E. Linkova, A. Burlakova, Alexander Mironov, V. Debabov (1995)
Atomic structure at 2.5 Å resolution of uridine phosphorylase from E. coli as refined in the monoclinic crystal latticeFEBS Letters, 367
M. Takehara, F. Ling, S. Izawa, Y. Inoue, A. Kimura (1995)
Molecular cloning and nucleotide sequence of purine nucleoside phosphorylase and uridine phosphorylase genes from Klebsiella sp.Bioscience, biotechnology, and biochemistry, 59 10
A. Drabikowska, L. Lissowska, Z. Veres, D. Shugar (1987)
Inhibitor properties of some 5-substituted uracil acyclonucleosides, and 2,2'-anhydrouridines versus uridine phosphorylase from E. coli and mammalian sources.Biochemical pharmacology, 36 23
T. Gasser, J. Moyer, R. Handschumacher (1981)
Novel single-pass exchange of circulating uridine in rat liver.Science, 213 4509
M. Kouni, F. Naguib, J. Niedzwicki, M. Iltzsch, S. Cha (1988)
Uridine phosphorylase from Schistosoma mansoni.The Journal of biological chemistry, 263 13
F. Ishikawa, K. Miyazono, U. Hellman, H. Drexler, C. Wernstedt, K. Hagiwara, K. Usuki, F. Takaku, W. Risau, C. Heldin (1989)
Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factorNature, 338
F. Dumler P. Cortes (1988)
P. Cortes, F. Dumler, and N. W. Levin, Am. J. Physiol. 255(4), Part 2, F635 (1988).
Z. Veres, A. Neszmélyi, A. Szabolcs, G. Dénes (1988)
Inhibition of uridine phosphorylase by pyrimidine nucleoside analogs and consideration of substrate binding to the enzyme based on solution conformation as seen by NMR spectroscopy.European journal of biochemistry, 178 1
F. Burling, R. Kniewel, J. Buglino, Tanya Chadha, A. Beckwith, Christopher Lima (2003)
Structure of Escherichia coli uridine phosphorylase at 2.0 A.Acta crystallographica. Section D, Biological crystallography, 59 Pt 1
J. Wiley (1997)
Seeking the nucleoside transporterNature Medicine, 3
N. Kemeny (1987)
Role of chemotherapy in the treatment of colorectal carcinoma.Seminars in surgical oncology, 3 3
G. Pizzorno, D. Cao, J. Leffert, R. Russell, Dekai Zhang, R. Handschumacher (2002)
Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update.Biochimica et biophysica acta, 1587 2-3
M. Endo, Noriko Shinbori, Y. Fukase, N. Sawada, T. Ishikawa, H. Ishitsuka, Yutaka Tanaka (1999)
Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5′‐deoxy‐5‐fluorouridine by cyclophosphamide in mammary tumor modelsInternational Journal of Cancer, 83
J. Darnowski, R. Handschumacher (1986)
Tissue uridine pools: evidence in vivo of a concentrative mechanism for uridine uptake.Cancer research, 46 7
S. Castronovo T. P. Roosild (2009)
10.1186/1472-6807-9-14BMC Struct. Biol., 9
J. Leer, K. Hammer-Jespersen, M. Schwartz (1977)
Uridine Phosphorylase from Escherichia coliFEBS Journal, 75
J. Niedzwicki, M. Kouni, Shih Chu, Sungman Cha (1983)
Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases.Biochemical pharmacology, 32 3
T. Roosild, S. Castronovo (2010)
Active Site Conformational Dynamics in Human Uridine Phosphorylase 1PLoS ONE, 5
A. Kanzaki, Y. Takebayashi, H. Bando, J. Eliason, Shin‐ichi Watanabe, H. Miyashita, M. Fukumoto, M. Toi, T. Uchida (2002)
Expression of uridine and thymidine phosphorylase genes in human breast carcinomaInternational Journal of Cancer, 97
C. Heidelberger, L. Griesbach, O. Cruz, R. Schnitzer, E. Grunberg (1958)
Fluorinated Pyrimidines VI. Effects of 5-Fluorouridine and 5-Fluoro-2′-Deoxyuridine on Transplanted Tumors.∗ †Proceedings of the Society for Experimental Biology and Medicine, 97
T. Pyrkov, A. Chugunov, N. Krylov, D. Nolde, R. Efremov (2009)
PLATINUM: a web tool for analysis of hydrophobic/hydrophilic organization of biomolecular complexesBioinformatics, 25 9
M. Dontsova, Y. Savochkina, A. Gabdoulkhakov, S. Baidakov, A. Lyashenko, M. Zolotukhina, L. Lopes, M. Garber, E. Morgunova, S. Nikonov, A. Mironov, S. Ealick, A. Mikhailov (2004)
Purification, crystallization and preliminary X-ray analysis of uridine phosphorylase from Salmonella typhimurium.Acta crystallographica. Section D, Biological crystallography, 60 Pt 4
D. Martin, R. Stolfi, R. Sawyer (2004)
Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridineCancer Chemotherapy and Pharmacology, 24
T. Morita, A. Matsuzaki, A. Tokue (2001)
Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNAInternational Journal of Cancer, 92
C. Lee, J. Sokoloski, A. Sartorelli, R. Handschumacher (1994)
Differentiation of HL-60 cells by dimethylsulfoxide activates a Na(+)-dependent nucleoside transport system.In vivo, 8 5
Z. Veres, I. Szinai, A. Szabolcs, K. Újszászy, G. Dénes (1987)
Biological activity of the potent uridine phosphorylase inhibitor 5-ethyl-2,2'-anhydrouridine.Drugs under experimental and clinical research, 13 10
C. Luccioni, J. Beaumatin, V. Bardot, D. Lefrançois (1994)
Pyrimidine nucleotide metabolism in human colon carcinomas: Comparison of normal tissues, primary tumors and xenograftsInternational Journal of Cancer, 58
G. Peters, J. Veerkamp (1983)
Purine and pyrimidine metabolism in peripheral blood lymphocytes.The International journal of biochemistry, 15 2
F. Naguib, J. Niedzwicki, M. Iltzsch, M. Wiemann, M. Kouni, S. Cha (1987)
Effects of N,N-dimethylformamide and sodium butyrate on enzymes of pyrimidine metabolism in cultured human tumor cells.Leukemia research, 11 10
D. Goette (1981)
Topical chemotherapy with 5-fluorouracil. A review.Journal of the American Academy of Dermatology, 4 6
R. Friesner, J. Banks, R. Murphy, T. Halgren, Jasna Klicic, Daniel Mainz, Matthew Repasky, E. Knoll, Mee Shelley, J. Perry, D. Shaw, Perry Francis, P. Shenkin (2004)
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.Journal of medicinal chemistry, 47 7
Shin‐ichi Watanabe, A. Hino, K. Wada, J. Eliason, T. Uchida (1995)
Purification, Cloning, and Expression of Murine Uridine Phosphorylase (*)The Journal of Biological Chemistry, 270
A. Zaniboni (1989)
The emerging role of 5-fluorouracil and leucovorin in the treatment of advanced breast cancer. A review.Journal of chemotherapy, 1 5
Schrödinger CombiGlide (2007)
CombiGlide, Schrödinger, LLC, New York (New York, 2007).
M. Dontsova, A. Gabdoulkhakov, O. Molchan, A. Lashkov, M. Garber, A. Mironov, N. Zhukhlistova, E. Morgunova, W. Voelter, C. Betzel, Yang Zhang, S. Ealick, A. Mikhailov (2005)
Preliminary investigation of the three-dimensional structure of Salmonella typhimurium uridine phosphorylase in the crystalline state.Acta crystallographica. Section F, Structural biology and crystallization communications, 61 Pt 4
P. Cortés, F. Dumler, N. Levin (1988)
Glomerular uracil nucleotide synthesis.The American journal of physiology, 255 4 Pt 2
B. Reigner, K. Blesch, E. Weidekamm (2001)
Clinical Pharmacokinetics of CapecitabineClinical Pharmacokinetics, 40
Robert Mader, C. Schrolnberger, B. Rizovski, Martin Brunner, C. Wenzel, G. Locker, Hans-Georg Eichler, Manfred Mueller, Günther Steger (2003)
Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancerBritish Journal of Cancer, 88
Y. Maehara, S. Moriguchi, Y. Emi, A. Watanabe, S. Kohnoe, S. Tsujitani, K. Sugimachi (1990)
Comparison of pyrimidine nucleotide synthetic enzymes involved in 5‐fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomasCancer, 66
E. Cadman, D. Dix, R. Handschumacher (1978)
Clinical, Biological, and Biochemical Effects of PyrazofurinCancer Research, 38
Iigo Masaaki, Nishikata Ken-Ichi, Nakajima Yoko, Szinai Istvan, Veres Zsuzsa, S. Anna, E. Clercq (1990)
Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.Biochemical Pharmacology, 39
M. Kouni, F. Naguib, S. Chu, S. Cha, T. Ueda, G. Gosselin, J. Imbach, Y. Shealy, B. Otter (1988)
Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase.Molecular pharmacology, 34 2
G. Connolly, J. Duley (1999)
Uridine and its nucleotides: biological actions, therapeutic potentials.Trends in pharmacological sciences, 20 5
W. Bu, E. Settembre, M. Kouni, S. Ealick (2005)
Structural basis for inhibition of Escherichia coli uridine phosphorylase by 5-substituted acyclouridines.Acta crystallographica. Section D, Biological crystallography, 61 Pt 7
Abstract The activation of xenobiotics often causes malignant tumor cells to resist chemotherapeutic treatment. Uridine phosphorylase is the key enzyme of pyrimidine metabolism and catalyzes the reversible phosphorylation of uridine with the formation of uracil and ribose-1-phosphate. High-selectivity anticancer agents based on uridine phosphorylase inhibitors are promising for treating both oncological and infection diseases. New medicinal preparations can be predicted and rationally developed only on the basis of detailed biomedical, structural, and functional knowledge about the biomacromolecular target enzyme-drug complex.
Crystallography Reports – Springer Journals
Published: Jul 1, 2011
Keywords: Crystallography and Scattering Methods
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.